ST Pharm: STP0404 HIV-1 treatment: Phase 2a clinical trial results received

Company receives Phase 2a clinical trial report for HIV-1 treatment

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

• 10.02 ★★ Report on major shareholding
• 09.18 ★★★★ API supply contract secured, worth 27.54% of revenue